多模态超声影像组学早期预测乳腺癌新辅助化疗病理完全缓解
该研究基于两阶段多模态超声影像组学特征与临床病理信息构建临床-影像组学模型,用于早期预测乳腺癌新辅助化疗后的病理完全缓解。回顾性构建集274例、回顾性测试集134例、前瞻性内部测试集76例,共484例。临床-影像组学模型在回顾性和前瞻性测试集的AUC分别为0.92(95%CI: 0.88, 0.94)和0.85(95%CI: 0.79, 0.89),显著高于影像组学模型、临床模型及放射科医生视觉评估。
要点
- 两阶段多模态超声影像组学联合临床病理信息可早期预测乳腺癌新辅助化疗后病理完全缓解。
- 临床-影像组学模型在回顾性测试集AUC为0.92(95%CI: 0.88, 0.94),前瞻性内部测试集AUC为0.85(95%CI: 0.79, 0.89)。
- 该模型辅助下放射科医生的预测效能显著提升。
核心结论
- 整合临床病理信息与两阶段多模态超声特征的临床-影像组学模型能够早期预测乳腺癌新辅助化疗后的病理完全缓解,预测效能良好。
研究设计与样本
- 回顾性收集2014年1月至2023年11月连续活检证实乳腺癌并接受多模态超声(新辅助化疗前及两周期后)后手术的患者,构建临床-影像组学模型(n=274)和回顾性测试(n=134);前瞻性内部测试集于2024年1月至2024年7月招募(n=76);总纳入484例。
诊断标准与关键数值
- 临床-影像组学模型在回顾性测试集AUC为0.92(95%CI: 0.88, 0.94),前瞻性内部测试集AUC为0.85(95%CI: 0.79, 0.89);影像组学模型AUC为0.75-0.85,临床模型AUC为0.68-0.72,放射科医生视觉评估AUC为0.59-0.68(所有p < 0.05)。
临床应用与阅片要点
- 放射科医生视觉评估预测病理完全缓解的AUC为0.59-0.68,在临床-影像组学模型辅助下预测效能显著提升。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
RATIONALE AND OBJECTIVES: To construct and validate a clinical-radiomics model based on radiomics features extracted from two-stage multimodal ultrasound and clinicopathologic information for early predicting pathologic complete response (pCR) to neoadjuvant chemotherapy (NAC) in breast cancer patients treated with NAC.
MATERIALS AND METHODS: Consecutive women with biopsy-proven breast cancer undergoing multimodal US pretreatment and after two cycles of NAC and followed by surgery between January 2014 and November 2023 were retrospectively collected for clinical-radiomics model construction (n = 274) and retrospective test (n = 134). The predictive performance of it was further tested in a subsequent prospective internal test set recruited between January 2024 to July 2024 (n = 76). Finally, a total of 484 patients were enrolled. The clinical-radiomics model predictive performance was compared with radiomics model, clinical model and radiologists' visual assessment by area under the receiver operating characteristic curve (AUC) analysis and DeLong test.
RESULTS: The proposed clinical-radiomics model obtained the AUC values of 0.92 (95%CI: 0.88, 0.94) and 0.85 (95%CI: 0.79, 0.89) in retrospective and prospective test sets, respectively, which were significantly higher than that those of the radiomics model (AUCs: 0.75-0.85), clinical model (AUCs: 0.68-0.72) and radiologists' visual assessments (AUCs:0.59-0.68) (all p < 0.05). In addition, the predictive efficacy of the radiologists was improved under the assistance of the clinical-radiomics model significantly.
CONCLUSION: The clinical-radiomics model developed in this study, which integrated clinicopathologic information and two-stage multimodal ultrasound features, was able to early predict pCR to NAC in breast cancer patients with favorable predictive effectiveness.
引用
- Wan CF, Jiang ZY, Wang YQ, et al. Radiomics of Multimodal Ultrasound for Early Prediction of Pathologic Complete Response to Neoadjuvant Chemotherapy in Breast Cancer. Acad Radiol. 2024. PMID: 39690072. doi:10.1016/j.acra.2024.11.012
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。